- Home
- MLTX vs NATH Comparison
MLTX vs NATH Comparison
Compare MLTX & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLTX
- NATH
- Stock Information
- Founded
- MLTX 2021
- NATH 1916
- Country
- MLTX Switzerland
- NATH United States
- Employees
- MLTX N/A
- NATH N/A
- Industry
- MLTX Biotechnology: Pharmaceutical Preparations
- NATH Restaurants
- Sector
- MLTX Health Care
- NATH Consumer Discretionary
- Exchange
- MLTX Nasdaq
- NATH Nasdaq
- Market Cap
- MLTX 535.3M
- NATH 442.2M
- IPO Year
- MLTX N/A
- NATH N/A
- Fundamental
- Price
- MLTX $9.40
- NATH $107.77
- Analyst Decision
- MLTX Buy
- NATH
- Analyst Count
- MLTX 9
- NATH 0
- Target Price
- MLTX $37.63
- NATH N/A
- AVG Volume (30 Days)
- MLTX 9.7M
- NATH 31.4K
- Earning Date
- MLTX 11-06-2025
- NATH 11-06-2025
- Dividend Yield
- MLTX N/A
- NATH 1.85%
- EPS Growth
- MLTX N/A
- NATH 9.62
- EPS
- MLTX N/A
- NATH 5.77
- Revenue
- MLTX N/A
- NATH $150,413,000.00
- Revenue This Year
- MLTX N/A
- NATH N/A
- Revenue Next Year
- MLTX N/A
- NATH N/A
- P/E Ratio
- MLTX N/A
- NATH $18.90
- Revenue Growth
- MLTX N/A
- NATH 6.38
- 52 Week Low
- MLTX $5.95
- NATH $75.15
- 52 Week High
- MLTX $62.75
- NATH $118.50
- Technical
- Relative Strength Index (RSI)
- MLTX 23.29
- NATH 51.38
- Support Level
- MLTX $6.56
- NATH $104.90
- Resistance Level
- MLTX $7.48
- NATH $113.59
- Average True Range (ATR)
- MLTX 2.22
- NATH 2.37
- MACD
- MLTX -4.37
- NATH 0.08
- Stochastic Oscillator
- MLTX 6.07
- NATH 50.14
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.